» Articles » PMID: 18485920

Presymptomatic Biochemical Changes in Hindlimb Muscle of G93A Human Cu/Zn Superoxide Dismutase 1 Transgenic Mouse Model of Amyotrophic Lateral Sclerosis

Overview
Specialties Biochemistry
Biophysics
Date 2008 May 20
PMID 18485920
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Amyotrophic lateral sclerosis (ALS) is primarily a motor neuron disorder. Intriguingly, early muscle denervation preceding motor neuron loss is observed in mouse models of ALS. Enhanced muscle vulnerability to denervation process has been suggested by accelerated muscle deterioration following peripheral nerve injury in an ALS mouse model. Here we provide evidence of biochemical changes in the hindlimb muscle of young, presymptomatic G93A hSOD1 transgenic mice. In this report, we demonstrate that cdk5 activity is reduced in hindlimb muscle of 27-day-old G93A hSOD1 transgenic mice. In vitro analysis revealed mutant hSOD1-mediated suppression of cdk5 activity. Furthermore, the decrease in muscle cdk5 activity was accompanied by a significant reduction in MyoD and cyclin D1 levels. These early muscle changes raise the possibility that the progressive deterioration of muscle function is potentiated by altered muscle biochemistry in these mice at a very young, presymptomatic age.

Citing Articles

New perspectives of the role of skeletal muscle derived extracellular vesicles in the pathogenesis of amyotrophic lateral sclerosis: the 'dying back' hypothesis.

Sbarigia C, Rome S, Dini L, Tacconi S J Extracell Biol. 2024; 3(11):e70019.

PMID: 39534483 PMC: 11555536. DOI: 10.1002/jex2.70019.


ALS Skeletal Muscle: Victim or Culprit.

Badu-Mensah A, Guo X, Hickman J Neurosci Chron. 2022; 2(2):31-33.

PMID: 35098252 PMC: 8793963. DOI: 10.46439/neuroscience.2.012.


Neuromuscular Development and Disease: Learning From and Models.

Fralish Z, Lotz E, Chavez T, Khodabukus A, Bursac N Front Cell Dev Biol. 2021; 9:764732.

PMID: 34778273 PMC: 8579029. DOI: 10.3389/fcell.2021.764732.


Running and swimming prevent the deregulation of the BDNF/TrkB neurotrophic signalling at the neuromuscular junction in mice with amyotrophic lateral sclerosis.

Just-Borras L, Hurtado E, Cilleros-Mane V, Biondi O, Charbonnier F, Tomas M Cell Mol Life Sci. 2019; 77(15):3027-3040.

PMID: 31646358 PMC: 11104938. DOI: 10.1007/s00018-019-03337-5.


The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis.

Loeffler J, Picchiarelli G, Dupuis L, Gonzalez De Aguilar J Brain Pathol. 2016; 26(2):227-36.

PMID: 26780251 PMC: 8029271. DOI: 10.1111/bpa.12350.


References
1.
Xiao Q, Zhao W, Beers D, Yen A, Xie W, Henkel J . Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia. J Neurochem. 2007; 102(6):2008-2019. DOI: 10.1111/j.1471-4159.2007.04677.x. View

2.
Weis J . Jun, Fos, MyoD1, and myogenin proteins are increased in skeletal muscle fiber nuclei after denervation. Acta Neuropathol. 1994; 87(1):63-70. DOI: 10.1007/BF00386255. View

3.
Miller T, Kim S, Yamanaka K, Hester M, Umapathi P, Arnson H . Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2006; 103(51):19546-51. PMC: 1748262. DOI: 10.1073/pnas.0609411103. View

4.
Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P . Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci. 2000; 20(7):2534-42. PMC: 6772256. View

5.
Li W, Brakefield D, Pan Y, Hunter D, Myckatyn T, Parsadanian A . Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp Neurol. 2006; 203(2):457-71. DOI: 10.1016/j.expneurol.2006.08.028. View